Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Oncology
New data illuminates research in oncology
August 18th, 2005
Data on oncology are outlined in reports from Poland and Japan. Study 1: Insulin receptor substrate 1 participates in breast cancer progression. According to recent research from Poland, "insulin receptor substrate 1 (IRS-1) transmits signals from the insulin-like growth factor 1 receptor (IGF-IR) and insulin receptor (IR) and has been associated with the pathogenesis of cancer. IRS-1 downregulation has been suggested to play a role in breast cancer progression, but no simultaneous assessments of IRS-1 expression in primary breast cancer and metastases have been performed." "To assess IRS-1 expression in primary and metastatic...
Source: Women's Health Weekly (2005-08-18)
|
